Article
Downregulation of Linc00173 increases BCL2 mRNA stability via the miR-1275/PROCA1/ZFP36L2 axis and induces acquired cisplatin resistance of lung adenocarcinoma
2022-04-12
Abstract excerpt
<h4>Background: </h4> LINC00173 had been reported as a cisplatin (cis-diamminedichloroplatinum, DDP) chemotherapy-resistant inducer in small cell lung cancer (SCLC) and lung squamous cell carcinoma (LUSC). Here, reversed data was displayed for LINC00173 as a DDP chemosensitivity-inducing factor in lung adenocarcinoma (LUAD). Methods LINC00173 was screened from GEO databases (GSE43493), then In situ hybridization...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4bd9b3c2-fa3e-5a1b-83b5-0128b0eb6d03
- DOI
- 10.21203/rs.3.rs-1518812/v1
